Intestinal liner holds promise for obesity, type 2 diabetes

09/18/2011 | InternalMedicineNews.com (free registration)

A small study presented at the European Society for the Study of Diabetes found that using a duodenal-jejunal bypass liner, an implantable weight-loss device, helped improve weight and blood glucose levels in obese patients with type 2 diabetes. The intestinal sleeve also increased the levels of incretin hormones glucagon-like peptide and peptide YY.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC